Utama › Penyakit Graft-versus-host
Kajian klinikal Penyakit Graft-versus-host sedang mengambil peserta di AS
34 kajian untuk Penyakit Graft-versus-host sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Boston, MA10 kajian
- New York City, NY7 kajian
- Columbus, OH6 kajian
- Atlanta, GA5 kajian
- Washington, DC5 kajian
- Portland, OR4 kajian
- Tampa, FL4 kajian
- St. Louis, MO4 kajian
- Detroit, MI4 kajian
- Pittsburgh, PA4 kajian
- Baldwin Park, CA4 kajian
- Miami, FL4 kajian
- Queens, NY4 kajian
- Seattle, WA4 kajian
- Nashville, TN3 kajian
- Cleveland, OH3 kajian
- Chicago, IL3 kajian
- Los Angeles, CA3 kajian
- East Norwalk, CT3 kajian
- Edison, NJ3 kajian
- New Rochelle, NY3 kajian
- Greenburgh, NY3 kajian
- Staten Island, NY3 kajian
- Houston, TX3 kajian
Mengikut negeri
- California9 kajian
- Florida7 kajian
- Georgia5 kajian
- Illinois3 kajian
- Kansas3 kajian
- Maryland5 kajian
- Massachusetts10 kajian
- Michigan5 kajian
- Missouri4 kajian
- New Jersey4 kajian
- New York10 kajian
- Ohio7 kajian
- Oregon4 kajian
- Pennsylvania6 kajian
- Tennessee3 kajian
- Texas4 kajian
- Washington4 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 60 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT00001529Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 70 · Wanita · Dikemas kini 29 Sep 2026 · NCT06649201Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Mengambil pesertaFasa 1/2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05531786Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06910969Evaluation of Patients With Immune Function Abnormalities
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Semua umur · Semua jantina · Dikemas kini 22 Sep 2026 · NCT00128973Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 7 hingga 80 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT00106925Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Ogo 2026 · NCT06450925Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Mengambil pesertaFasa 1
Umur 18 hingga 90 · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT06392711Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07565220Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD
Mengambil pesertaFasa 1
Umur 2 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT06991361A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07359859Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT07216443Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 1 Jul 2026 · NCT06996119A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jun 2026 · NCT07006506Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06815003A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Mengambil pesertaFasa 2
Umur 2 ke atas · Semua jantina · Dikemas kini 16 Jun 2026 · NCT04710576Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)
Mengambil pesertaFasa 1/2
Umur 14 hingga 100 · Semua jantina · Dikemas kini 29 Mei 2026 · NCT05289167A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant
Mengambil pesertaFasa 2
Umur 4 ke atas · Semua jantina · Dikemas kini 22 Mei 2026 · NCT05675930A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 20 Mei 2026 · NCT06615050Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Mengambil pesertaFasa 2
Sehingga umur 26 · Semua jantina · Dikemas kini 14 Mei 2026 · NCT07566377Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Mengambil pesertaFasa 2
Umur 2 ke atas · Semua jantina · Dikemas kini 11 Mei 2026 · NCT04380740Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Apr 2026 · NCT06008808Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT07356245Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Apr 2026 · NCT06434363A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
Mengambil peserta
Sehingga umur 30 · Semua jantina · Dikemas kini 13 Apr 2026 · NCT04337515Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.